Skip to main content
MRNA logo

MRNA · Moderna, Inc. · Analyst Estimates

Track MRNA — free
$191.23 -12.23 (-6.01%) At close · Sep 30
Market Cap
$79.40B
Shares
399.24M
Volume · Sep 30 20.66M Avg daily vol (3M) 16.95M

Analyst Estimates

Compare analyst forecasts for Moderna, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-25 23:45 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-10.55
-8.3833
-6.66
—
-8.54354
-8.65851
-8.3833
-8.63068
— — — —
EPS
analysts
Publication date not stated
— — —
20
— — — —
1
1
7
3
Revenue
USD
Publication date not stated
1963600000
2100558050
2154500000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
20
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-7.11
-4.78698
-2.73
—
-4.92145
-4.751
-4.78698
-4.68935
— — — —
EPS
analysts
Publication date not stated
— — —
20
— — — —
4
1
6
2
Revenue
USD
Publication date not stated
1915000000
2438038630
3290000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
19
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-3.32
-1.28924
-0.53
—
-1.35067
-1.22728
-1.28924
-1.12916
— — — —
EPS
analysts
Publication date not stated
— — —
14
— — — —
0
0
4
2
Revenue
USD
Publication date not stated
827000000
894969750
1123000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
12
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-2.09
-1.74156
-0.63
—
-1.8687
-2.06652
-1.74156
-1.97498
— — — —
EPS
analysts
Publication date not stated
— — —
14
— — — —
0
0
5
3
Revenue
USD
Publication date not stated
379000000
667792830
734000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
12
— — — — — — — —
Key facts CIK 1682852 CUSIP 60770K107 13F (30d) 32 filings 16 filers Visit website Investor relations